X0306 4 2014-06-17 false 0000911326 SYNAGEVA BIOPHARMA CORP GEVA 0001384243 Quart Barry D 33 HAYDEN AVE LEXINGTON MA 02421 true false false false Common Stock 2014-06-17 4 M false 1000 23.95 A 1000 D Common Stock 2014-06-17 4 S false 1000 90 D 0 D Stock Option (Right to Buy) 23.95 2014-06-17 4 M false 1000 0 D 2017-06-27 Common Stock 1000 1000 D The stock option exercise and sale of shares of common stock ("Shares") reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan adopted by the reporting person on March 10, 2014. The reporting person previously transferred an option to purchase 2,000 Shares of the original 4,000 granted under this stock option, which transfer was not previously reported as permitted under Rule 16a-12 of the Securities Exchange Act. The stock option granted the reporting person an option to purchase 4,000 Shares. These options vested one-third every year over a three-year period and became exercisable on the following schedule: 33.33% on June 27, 2008, 33.33% on June 27, 2009, 33.33% on June 27, 2010. /s/ Thomas W. Beetham, Attorney-in-Fact 2014-06-19